ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2026
Anything that helps: cancer patient and carer perspectives on psychedelic-assisted therapy.
Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeThe potential of psychedelic-assisted therapies (PAT) to address existential distress in cancer populations is attracting increasing attention. However, this novel approach is challenged by stigma, hype, and misconceptions. The current study aimed to investigate the knowledge, beliefs, and attitudes of advanced cancer patients and carers regarding psychedelics and their potential therapeutic use in treating cancer-related distress.
methodsFifteen semi-structured interviews were conducted with cancer patients and carers. Participants needed to be at least 18 years old and either diagnosed with stage 4 cancer and have mild to moderate distress as measured by the General Anxiety Disorder 7-Item Scale and Patient Health Questionnaire 9, or be caring for someone with advanced cancer. Data were analysed using reflexive thematic analysis.
resultsPrimary themes centred around how the perspective of cancer patients and their carers changes at the end of life, and the importance of balancing safety and risk with potential benefits. Participants expressed largely positive views of PAT, recognising that with few available options and often poor quality of life, any intervention offering potential benefit was worthwhile. However, acceptance of PAT was tempered by a desire to minimise risk and concerns about safety.
conclusionOur findings demonstrate that cancer patients and their carers are open to the idea of psychedelic therapies as long as risk is carefully managed. It is important that the perspectives of patients and carers are included in developing PAT interventions given their potential to offer a meaningful option in improving the lives of those with advanced cancer.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.